CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)

Detalles Bibliográficos
Autores principales: Khan, SN, DaSilva, C, Renella, P, Satou, G, Ayad, I, Patel, S, Boechat, I, Finn, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Workshop Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560090/
http://dx.doi.org/10.1186/1532-429X-15-S1-W32
_version_ 1782257729329430528
author Khan, SN
DaSilva, C
Renella, P
Satou, G
Ayad, I
Patel, S
Boechat, I
Finn, P
author_facet Khan, SN
DaSilva, C
Renella, P
Satou, G
Ayad, I
Patel, S
Boechat, I
Finn, P
author_sort Khan, SN
collection PubMed
description
format Online
Article
Text
id pubmed-3560090
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35600902013-02-04 CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine) Khan, SN DaSilva, C Renella, P Satou, G Ayad, I Patel, S Boechat, I Finn, P J Cardiovasc Magn Reson Workshop Presentation BioMed Central 2013-01-30 /pmc/articles/PMC3560090/ http://dx.doi.org/10.1186/1532-429X-15-S1-W32 Text en Copyright ©2013 Khan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Workshop Presentation
Khan, SN
DaSilva, C
Renella, P
Satou, G
Ayad, I
Patel, S
Boechat, I
Finn, P
CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
title CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
title_full CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
title_fullStr CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
title_full_unstemmed CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
title_short CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
title_sort cemra in neonatal and pediatric congenital vascular diseases at 1.5t and 3.0t: comparison of an intravascular contrast agent (gadofosveset) with an extracellular agent (gadopentetate dimeglumine)
topic Workshop Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560090/
http://dx.doi.org/10.1186/1532-429X-15-S1-W32
work_keys_str_mv AT khansn cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine
AT dasilvac cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine
AT renellap cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine
AT satoug cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine
AT ayadi cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine
AT patels cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine
AT boechati cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine
AT finnp cemrainneonatalandpediatriccongenitalvasculardiseasesat15tand30tcomparisonofanintravascularcontrastagentgadofosvesetwithanextracellularagentgadopentetatedimeglumine

Ejemplares similares